Has Manuel Estrada received payments from drug or device companies?

Yes. Drug and device makers reported $8,598 in general payments to Manuel Estrada across 440 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Manuel Estrada did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Manuel Estrada come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Manuel Estrada

Psychiatric/Mental Health · El Paso, TXNPI 1932791878

Payments from drug & device makers

$8,598in general payments, 2019–2025

Across 440 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Alkermes, Inc.$1K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
Neurocrine Biosciences, Inc.$668
Corium, LLC$637
Axsome Therapeutics, Inc.$577
plus $3K from 10 others

What the payments were for

Food & beverage$8,589100%
Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	78	$1,251
Alkermes, Inc.	91	$1,141
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	43	$1,124
Neurocrine Biosciences, Inc.	29	$668
Corium, LLC	33	$637
Axsome Therapeutics, Inc.	24	$577
Supernus Pharmaceuticals, Inc.	19	$576
Johnson & Johnson	21	$571
Otsuka America Pharmaceutical, Inc.	29	$515
E.r. Squibb & Sons, L.L.C.	18	$419
Teva Pharmaceuticals USA, Inc.	14	$394
Takeda Pharmaceuticals U.S.A., Inc.	18	$368
Lundbeck LLC	13	$196
Ironshore Pharmaceuticals Inc.	6	$91
Collegium Pharmaceutical, Inc.	3	$44
Sunovion Pharmaceuticals Inc.	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,598 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	26	$64,704
VraylarCariprazine Hcl	14	$21,657
RexultiBrexpiprazole	13	$19,816
Paliperidone ErPaliperidone	13	$3,277
Ramelteon	24	$2,405
Aripiprazole	64	$2,221
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	13	$2,068
Trazodone Hcl	155	$1,488
Venlafaxine Hcl ErVenlafaxine Hcl	53	$1,089
Quetiapine Fumarate	98	$903
Buspirone Hcl	47	$747
Hydroxyzine Hcl	43	$653
Bupropion XlBupropion Hcl	48	$650
Clonazepam	67	$597
Duloxetine Hcl	31	$524

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna	$571	$64,70426 claims
AbbVieVraylar	$1,251	$21,65714 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$515	$19,81613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in El Paso

Victor IlogEl Paso$167K
Alfredo ArellanoEl Paso$55K
Tracy HicksLongview$684K
Natalie TellezHouston$602K
Karah BrashierRichardson$567K
Grant DavisRichardson$360K
Lisa ShamblinGrapevine$163K
Monique GonzalezSan Antonio$126K
Marguerite AddisonWaco$118K
Komi Kokou-AbiRound Rock$88K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →